Neoplasm Staging
Research News and Information

Saturday, November 21, 2009

Clinical staging error in prostate cancer: localization and relevance of undetected tumour areas.

20 Dec 2009 OBJECTIVE: To describe the localization and to assess the clinical implications of areas of undetected prostate cancer in radical prostatectomy (RP) specimens, focusing on patients with unilaterally negative preoperative biopsy cores. PATIENTS AND ... Read more...

Neuroblastoma involvement of the falx cerebri.

13 Dec 2009 Involvement of the falx cerebri in infants with stage 4 neuroblastoma is thought to be rare. The falx is derived from the neural crest and thus may be a location for primary neuroblastoma. Its propensity for metastasis is unknown. Management of ... Read more...

A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy.

13 Dec 2009 An asymptomatic 11-week-old male received no treatment after he was classified as having a suspected atypical form of MYCN-nonamplified hyperdiploid stage 4S neuroblastoma (NB), with masses in an adrenal gland, subcutaneous tissues, and the falx ... Read more...

Latest indexed articles for 'Neoplasm Staging'

These are the very latest articles for this heading:

• Clinical staging error in prostate cancer: localization and relevance of undetected tumour areas. 20 Dec 2009
• Neuroblastoma involvement of the falx cerebri. 13 Dec 2009
• A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy. 13 Dec 2009
• Gene expression profiling: decoding breast cancer. 29 Nov 2009
• Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group. 29 Nov 2009
• Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group study in United States. 13 Nov 2009
• Distinct progression-associated expression of tumor and stromal MMPs in HaCaT skin SCCs correlates with onset of invasion. 13 Nov 2009
• Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines. 13 Nov 2009
• The potential impact of human papillomavirus vaccination in contemporary cytologically screened populations may be underestimated: an observational retrospective analysis of invasive cervical cancers. 13 Nov 2009
• Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma. 30 Oct 2009
• Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parameters. 30 Oct 2009
• The prognostic impact of main bronchial lymph node involvement in non-small cell lung carcinoma: suggestions for a modification of the staging system. 30 Oct 2009
• Impact of surgical staging in locally advanced cervical cancer and subsequent chemotherapy. 30 Oct 2009
• BRAF mutational analysis in papillary carcinomas with mixed follicular and papillary growth patterns. 30 Oct 2009
• Does the negative node count affect disease-free survival in early-stage oral cavity cancer? 30 Oct 2009
• Phase II trial of thalidomide, irinotecan and gemcitabine in chemonaive patients with advanced non-small cell lung cancer. 30 Oct 2009
• Association of polymorphisms in regulatory regions of interleukin-12p40 gene and cytokine serum level with colorectal cancer. 30 Oct 2009
• Influence of narrow band imaging (NBI) videobronchoscopy on the assessment of central lung cancer extension and therapeutic decision. 30 Oct 2009
• Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis. 30 Oct 2009
• Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival. 18 Oct 2009

See a longer list of these articles.

Technical information about 'Neoplasm Staging'

Definition: Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.

Descriptor UI: D009367

Alternative terms: Neoplasm Staging; Tumor Staging; Staging, Tumor; Cancer Staging; Staging, Cancer; Staging, Neoplasm;

Allowable Qualifiers: adverse effects; classification; economics; history; instrumentation; methods; mortality; nursing; psychology; standards; trends; utilization; veterinary; statistics & numerical data; contraindications; ethics;

Tree Number: E01.370.550;

History Note: 78

Technical Notes: = degree of spread of neopl (do not confuse with "grading" which = degree of malignancy); staging is given in roman numerals, grading in arabic; Manual 24.4.1.12+; usually NIM with no qualif + neopl terms /pathol (IM); IM as technique & general only & when IM, qualif permitted; relation to /pathol & differentiation from classification: TN 214; DF: NEOPL STAGING